vs
Side-by-side financial comparison of Charter Communications (CHTR) and Merck & Co. (MRK). Click either name above to swap in a different company.
Merck & Co. is the larger business by last-quarter revenue ($16.4B vs $13.6B, roughly 1.2× Charter Communications). Merck & Co. runs the higher net margin — 18.1% vs 8.6%, a 9.5% gap on every dollar of revenue. On growth, Merck & Co. posted the faster year-over-year revenue change (5.0% vs -1.0%). Merck & Co. produced more free cash flow last quarter ($1.8B vs $1.4B). Over the past eight quarters, Merck & Co.'s revenue compounded faster (2.0% CAGR vs -0.3%).
Charter Communications, Inc., is an American telecommunications and mass media company with services branded as Spectrum. The company is headquartered in Stamford, Connecticut.
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fourth on the list of largest biomedical companies by revenue.
CHTR vs MRK — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.6B | $16.4B |
| Net Profit | $1.2B | $3.0B |
| Gross Margin | — | 66.2% |
| Operating Margin | 23.6% | 20.9% |
| Net Margin | 8.6% | 18.1% |
| Revenue YoY | -1.0% | 5.0% |
| Net Profit YoY | -4.4% | -20.8% |
| EPS (diluted) | $9.17 | $1.19 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $13.6B | — | ||
| Q4 25 | $13.6B | $16.4B | ||
| Q3 25 | $13.7B | $17.3B | ||
| Q2 25 | $13.8B | $15.8B | ||
| Q1 25 | $13.7B | $15.5B | ||
| Q4 24 | $13.9B | $15.6B | ||
| Q3 24 | $13.8B | $16.7B | ||
| Q2 24 | $13.7B | $16.1B |
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.3B | $3.0B | ||
| Q3 25 | $1.1B | $5.8B | ||
| Q2 25 | $1.3B | $4.4B | ||
| Q1 25 | $1.2B | $5.1B | ||
| Q4 24 | $1.5B | $3.7B | ||
| Q3 24 | $1.3B | $3.2B | ||
| Q2 24 | $1.2B | $5.5B |
| Q1 26 | — | — | ||
| Q4 25 | — | 66.2% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 77.5% | ||
| Q1 25 | — | 78.0% | ||
| Q4 24 | — | 75.5% | ||
| Q3 24 | — | 75.5% | ||
| Q2 24 | — | 76.8% |
| Q1 26 | 23.6% | — | ||
| Q4 25 | 24.0% | 20.9% | ||
| Q3 25 | 22.9% | 39.0% | ||
| Q2 25 | 23.8% | 31.6% | ||
| Q1 25 | 23.6% | 38.0% | ||
| Q4 24 | 24.3% | 26.7% | ||
| Q3 24 | 24.2% | 24.6% | ||
| Q2 24 | 23.8% | 37.3% |
| Q1 26 | 8.6% | — | ||
| Q4 25 | 9.8% | 18.1% | ||
| Q3 25 | 8.3% | 33.5% | ||
| Q2 25 | 9.5% | 28.0% | ||
| Q1 25 | 8.9% | 32.7% | ||
| Q4 24 | 10.5% | 24.0% | ||
| Q3 24 | 9.3% | 19.0% | ||
| Q2 24 | 9.0% | 33.9% |
| Q1 26 | $9.17 | — | ||
| Q4 25 | $10.27 | $1.19 | ||
| Q3 25 | $8.34 | $2.32 | ||
| Q2 25 | $9.18 | $1.76 | ||
| Q1 25 | $8.42 | $2.01 | ||
| Q4 24 | $10.11 | $1.49 | ||
| Q3 24 | $8.82 | $1.24 | ||
| Q2 24 | $8.49 | $2.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $517.0M | $14.6B |
| Total DebtLower is stronger | $94.4B | — |
| Stockholders' EquityBook value | $21.1B | $52.6B |
| Total Assets | $154.6B | $136.9B |
| Debt / EquityLower = less leverage | 4.48× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $517.0M | — | ||
| Q4 25 | $477.0M | $14.6B | ||
| Q3 25 | $464.0M | $18.2B | ||
| Q2 25 | $606.0M | $8.6B | ||
| Q1 25 | $796.0M | $9.2B | ||
| Q4 24 | $459.0M | $13.7B | ||
| Q3 24 | $721.0M | $14.6B | ||
| Q2 24 | $602.0M | $11.4B |
| Q1 26 | $94.4B | — | ||
| Q4 25 | $94.8B | — | ||
| Q3 25 | $95.2B | — | ||
| Q2 25 | $94.4B | — | ||
| Q1 25 | $93.8B | — | ||
| Q4 24 | $93.9B | — | ||
| Q3 24 | $95.3B | — | ||
| Q2 24 | $96.7B | — |
| Q1 26 | $21.1B | — | ||
| Q4 25 | $16.1B | $52.6B | ||
| Q3 25 | $15.3B | $51.9B | ||
| Q2 25 | $16.2B | $49.0B | ||
| Q1 25 | $16.2B | $48.3B | ||
| Q4 24 | $15.6B | $46.3B | ||
| Q3 24 | $14.1B | $44.5B | ||
| Q2 24 | $12.9B | $43.6B |
| Q1 26 | $154.6B | — | ||
| Q4 25 | $154.2B | $136.9B | ||
| Q3 25 | $152.8B | $129.5B | ||
| Q2 25 | $151.6B | $117.5B | ||
| Q1 25 | $151.0B | $115.1B | ||
| Q4 24 | $150.0B | $117.1B | ||
| Q3 24 | $149.4B | $117.5B | ||
| Q2 24 | $148.6B | $112.6B |
| Q1 26 | 4.48× | — | ||
| Q4 25 | 5.90× | — | ||
| Q3 25 | 6.20× | — | ||
| Q2 25 | 5.82× | — | ||
| Q1 25 | 5.77× | — | ||
| Q4 24 | 6.03× | — | ||
| Q3 24 | 6.76× | — | ||
| Q2 24 | 7.51× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $2.9B |
| Free Cash FlowOCF − Capex | $1.4B | $1.8B |
| FCF MarginFCF / Revenue | 10.1% | 11.1% |
| Capex IntensityCapex / Revenue | 21.0% | 6.3% |
| Cash ConversionOCF / Net Profit | — | 0.96× |
| TTM Free Cash FlowTrailing 4 quarters | $4.0B | $12.4B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $3.8B | $2.9B | ||
| Q3 25 | $4.5B | $7.8B | ||
| Q2 25 | $3.6B | $3.3B | ||
| Q1 25 | $4.2B | $2.5B | ||
| Q4 24 | $3.5B | $3.5B | ||
| Q3 24 | $3.9B | $9.3B | ||
| Q2 24 | $3.9B | $5.6B |
| Q1 26 | $1.4B | — | ||
| Q4 25 | $426.0M | $1.8B | ||
| Q3 25 | $1.4B | $6.8B | ||
| Q2 25 | $726.0M | $2.5B | ||
| Q1 25 | $1.8B | $1.2B | ||
| Q4 24 | $398.0M | $2.5B | ||
| Q3 24 | $1.3B | $8.5B | ||
| Q2 24 | $1.0B | $4.8B |
| Q1 26 | 10.1% | — | ||
| Q4 25 | 3.1% | 11.1% | ||
| Q3 25 | 10.5% | 39.6% | ||
| Q2 25 | 5.3% | 16.0% | ||
| Q1 25 | 13.4% | 7.5% | ||
| Q4 24 | 2.9% | 16.1% | ||
| Q3 24 | 9.7% | 51.1% | ||
| Q2 24 | 7.3% | 30.1% |
| Q1 26 | 21.0% | — | ||
| Q4 25 | 24.5% | 6.3% | ||
| Q3 25 | 22.3% | 5.7% | ||
| Q2 25 | 20.9% | 4.8% | ||
| Q1 25 | 17.5% | 8.6% | ||
| Q4 24 | 22.0% | 6.0% | ||
| Q3 24 | 18.6% | 4.7% | ||
| Q2 24 | 20.8% | 4.9% |
| Q1 26 | — | — | ||
| Q4 25 | 2.82× | 0.96× | ||
| Q3 25 | 3.94× | 1.35× | ||
| Q2 25 | 2.77× | 0.74× | ||
| Q1 25 | 3.48× | 0.49× | ||
| Q4 24 | 2.36× | 0.92× | ||
| Q3 24 | 3.05× | 2.94× | ||
| Q2 24 | 3.13× | 1.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CHTR
| Internet | $5.9B | 43% |
| Video | $3.3B | 24% |
| Small business | $1.1B | 8% |
| Mobile service | $1.1B | 8% |
| Other | $906.0M | 7% |
| Mid-market & large business | $749.0M | 6% |
| Advertising sales | $358.0M | 3% |
| Voice | $338.0M | 2% |
MRK
| Pharmaceuticalsegment | $8.7B | 53% |
| Keytruda | $4.9B | 30% |
| Other | $2.7B | 16% |
| Janumet | $57.0M | 0% |
| Isentress Isentress HD | $38.0M | 0% |
| Pifeltro | $25.0M | 0% |
| Belsomra | $23.0M | 0% |
| Dificid | $17.0M | 0% |
| Delstrigo | $14.0M | 0% |
| Lagevrio | $12.0M | 0% |
| Pneumovax23 | $4.0M | 0% |
